The Egyptian clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease

• DOI: 10.4103/sjg.sjg_357_21
• Publication Date: 2022-01-25T09:14:52Z
• Authors: Yasser Fouad; Gamal Esmat; Reda Elwakil; Serag Zakaria; Ayman Yosry; Imam Waked; Maissa El-Razky; Wahid Doss; Magdy El-Serafy; Ebraheem Mostafa; Mahmood Anees; Mohamed A. Sakr; Nadia AbdelAty; Ashraf Omar; Samy Zaki; Amgad Al-zahaby; Hamdy Mahfouz; Maysaa Abdalla; Mahmoud Albendary; Abdel-Khalek Hamed; Ahmed Gomaa; Adel Hasan; Sherif Abdel-baky; Medhat El sahhar; Gamal Shiha; Dina Attia; Ebada Saeed; Enas Kamal; Shamardan Bazeed; Mai Mehrez; Shereen Abdelaleem; Yasmine Gaber; Mohammed Abdallah; Asmaa Salama; Doaa A. Tawab; Shaymaa Nafady
• Keywords: 0303 health sciences; 03 medical and health sciences; Non-alcoholic Fatty Liver Disease; Prevalence; Humans; Mass Screening; Egypt; Clinical Practice Guidelines; 3. Good health

The landscape of chronic liver disease in Egypt has drastically changed over the past few decades. The prevalence of metabolic-associated fatty liver disease (MAFLD) has risen to alarming levels. Despite the magnitude of the problem, no regional guidelines have been developed to tackle this disease. This document provides the clinical practice guidelines of the key Egyptian opinion leaders on MAFLD screening, diagnosis, and management, and covers various aspects in the management of MAFLD. The document considers our local situations and the burden of clinical management for the healthcare sector and is proposed for daily clinical practical use. Particular reference to special groups was done whenever necessary.